298: A dilemma in ALS, the first MASH drug, & why gene therapy is hard
The Readout Loud
00:00
Landmark Approval of First Medicine for Fatty Liver Disease
Exploring the FDA approval of Resmederon, the first medicine for a common fatty liver disease, shedding light on its market potential and the key players driving its development and commercialization.
Transcript
Play full episode
